Loading data
CDLXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 212.33 m USD | 255.61 m USD | 285.43 m USD | 277.19 m USD | 258.75 m USD |
| Research and development expense | 39.77 m USD | 49.61 m USD | 51.35 m USD | 54.44 m USD | 38.1 m USD |
| Operating profit | -101.82 m USD | -195.5 m USD | -135.67 m USD | -457.78 m USD | -122.6 m USD |
| Profit before tax | -103.49 m USD | -189.3 m USD | -134.7 m USD | -466.71 m USD | -136.43 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | -1.45 m USD | -7.86 m USD |
| Net income (reported basis) | -104 m USD | -189 m USD | -135 m USD | -465 m USD | -129 m USD |
| Net income attributable to common shareholders | — | — | -134.7 m USD | -465.26 m USD | -128.57 m USD |
| Basic earnings per share | -1.95 USD/share | -3.91 USD/share | -3.69 USD/share | -13.92 USD/share | -3.99 USD/share |
| Diluted earnings per share | -1.95 USD/share | -3.91 USD/share | -3.69 USD/share | -13.92 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.